These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34166315)

  • 1. HIV-1 Recent Infection Testing Algorithm With Antiretroviral Drug Detection to Improve Accuracy of Incidence Estimates.
    Voetsch AC; Duong YT; Stupp P; Saito S; McCracken S; Dobbs T; Winterhalter FS; Williams DB; Mengistu A; Mugurungi O; Chikwanda P; Musuka G; Ndongmo CB; Dlamini S; Nuwagaba-Biribonwoha H; Pasipamire M; Tegbaru B; Eshetu F; Biraro S; Ward J; Aibo D; Kabala A; Mgomella GS; Malewo O; Mushi J; Payne D; Mengistu Y; Asiimwe F; Shang JD; Dokubo EK; Eno LT; Zoung-Kanyi Bissek AC; Kingwara L; Junghae M; Kiiru JN; Mwesigwa RCN; Balachandra S; Lobognon R; Kampira E; Detorio M; Yufenyuy EL; Brown K; Patel HK; Parekh BS
    J Acquir Immune Defic Syndr; 2021 Aug; 87(Suppl 1):S73-S80. PubMed ID: 34166315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy.
    Kim AA; Rehle T
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):863-866. PubMed ID: 29926735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
    Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
    BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland.
    Duong YT; Dobbs T; Mavengere Y; Manjengwa J; Rottinghaus E; Saito S; Bock N; Philip N; Justman J; Bicego G; Nkengasong JN; Parekh BS
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):896-905. PubMed ID: 31204867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.
    Moyo S; Gaseitsiwe S; Mohammed T; Pretorius Holme M; Wang R; Kotokwe KP; Boleo C; Mupfumi L; Yankinda EK; Chakalisa U; van Widenfelt E; Gaolathe T; Mmalane MO; Dryden-Peterson S; Mine M; Lebelonyane R; Bennett K; Leidner J; Wirth KE; Tchetgen Tchetgen E; Powis K; Moore J; Clarke WA; Lockman S; Makhema JM; Essex M; Novitsky V
    PLoS One; 2018; 13(10):e0204840. PubMed ID: 30356287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of non-disclosure of HIV status and antiretroviral therapy on HIV recency testing and incidence algorithms.
    van den Berg K; Murphy EL; Maartens G; Louw VJ; Grebe E
    Vox Sang; 2024 Jun; 119(6):581-589. PubMed ID: 38622931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV drug resistance profile in South Africa: Findings and implications from the 2017 national HIV household survey.
    Moyo S; Hunt G; Zuma K; Zungu M; Marinda E; Mabaso M; Kana V; Kalimashe M; Ledwaba J; Naidoo I; Takatshana S; Matjokotja T; Dietrich C; Raizes E; Diallo K; Kindra G; Mugore L; Rehle T
    PLoS One; 2020; 15(11):e0241071. PubMed ID: 33147285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating HIV incidence in the Akwa Ibom AIDS indicator survey (AKAIS), Nigeria using the limiting antigen avidity recency assay.
    Negedu-Momoh OR; Balogun O; Dafa I; Etuk A; Oladele EA; Adedokun O; James E; Pandey SR; Khamofu H; Badru T; Robinson J; Mastro TD; Torpey K
    J Int AIDS Soc; 2021 Feb; 24(2):e25669. PubMed ID: 33619853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of a novel rapid test for recent HIV infection among newly-diagnosed pregnant adolescent girls and young women in four high-HIV-prevalence districts-Malawi, 2017-2018.
    Agyemang EA; Kim AA; Dobbs T; Zungu I; Payne D; Maher AD; Curran K; Kim E; Kwalira H; Limula H; Adhikari A; Welty S; Kandulu J; Nyirenda R; Auld AF; Rutherford GW; Parekh BS
    PLoS One; 2022; 17(2):e0262071. PubMed ID: 35148312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of HIV Incidence in the Zimbabwe Population-Based HIV Impact Assessment Survey (2015-2016) with Modeled Estimates: Progress Toward Epidemic Control.
    Gonese E; Musuka G; Ruangtragool L; Hakim A; Parekh B; Dobbs T; Duong YT; Patel H; Mhangara M; Mugurungi O; Mapingure M; Saito S; Herman-Roloff A; Gwanzura L; Tippett-Barr B; Kilmarx PH; Justman J
    AIDS Res Hum Retroviruses; 2020 Aug; 36(8):656-662. PubMed ID: 32498542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of viral load to improve survey estimates of known HIV-positive status and antiretroviral treatment coverage.
    Young PW; Zielinski-Gutierrez E; Wamicwe J; Mukui I; Kim AA; Waruru A; Zeh C; Kretzschmar ME; De Cock KM
    AIDS; 2020 Mar; 34(4):631-636. PubMed ID: 31794520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
    Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of multi-assay algorithms for cross-sectional HIV incidence estimation in settings with universal antiretroviral treatment.
    Grant-McAuley W; Laeyendecker O; Monaco D; Chen A; Hudelson SE; Klock E; Brookmeyer R; Morrison D; Piwowar-Manning E; Morrison CS; Hayes R; Ayles H; Bock P; Kosloff B; Shanaube K; Mandla N; van Deventer A; Ruczinski I; Kammers K; Larman HB; Eshleman SH
    BMC Infect Dis; 2022 Nov; 22(1):838. PubMed ID: 36368950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of population-level HIV-1 incidence estimation by cross-sectional incidence assays in the HPTN 071 (PopART) trial.
    Klock E; Wilson E; Fernandez RE; Piwowar-Manning E; Moore A; Kosloff B; Bwalya J; Bell-Mandla N; James A; Ayles H; Bock P; Donnell D; Fidler S; Hayes R; Eshleman SH; Laeyendecker O;
    J Int AIDS Soc; 2021 Dec; 24(12):e25830. PubMed ID: 34897992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent HIV Infection Among Men Who Have Sex with Men, Transgender Women, and Genderqueer Individuals with Newly Diagnosed HIV Infection in Zimbabwe: Results from a Respondent-Driven Sampling Survey.
    Parmley LE; Harris TG; Hakim AJ; Musuka G; Chingombe I; Mugurungi O; Moyo B; Mapingure M; Gozhora P; Samba C; Rogers JH
    AIDS Res Hum Retroviruses; 2022 Nov; 38(11):834-839. PubMed ID: 35923140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.
    Huik K; Soodla P; Pauskar M; Owen SM; Luo W; Murphy G; Jõgeda EL; Kallas E; Rajasaar H; Avi R; Masciotra S; Lutsar I;
    PLoS One; 2019; 14(5):e0217048. PubMed ID: 31125356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART).
    Grant-McAuley W; Klock E; Laeyendecker O; Piwowar-Manning E; Wilson E; Clarke W; Breaud A; Moore A; Ayles H; Kosloff B; Shanaube K; Bock P; Mandla N; van Deventer A; Fidler S; Donnell D; Hayes R; Eshleman SH;
    PLoS One; 2021; 16(12):e0258644. PubMed ID: 34919554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic.
    Grant-McAuley W; Fogel JM; Galai N; Clarke W; Breaud A; Marzinke MA; Mbwambo J; Likindikoki S; Aboud S; Donastorg Y; Perez M; Barrington C; Davis W; Kerrigan D; Eshleman SH
    PLoS One; 2020; 15(10):e0240890. PubMed ID: 33119663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recency of HIV infection, antiretroviral therapy use and viral loads among symptomatic sexually transmitted infection service attendees in South Africa.
    Kufa T; Radebe F; Cutler E; Goosen M; Wiesner L; Greyling D; Maseko V; Kularatne R; Puren A
    S Afr Med J; 2022 Feb; 112(2):13502. PubMed ID: 35139990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the impact of antiretroviral and antiseizure medication interactions on treatment effectiveness among outpatient clinic attendees with HIV in Zambia.
    Navis A; Dallah I; Mabeta C; Musukuma K; Siddiqi OK; Bositis CM; Koralnik IJ; Gelbard HA; Theodore WH; Okulicz JF; Johnson BA; Sikazwe I; Bearden DR; Birbeck GL
    Epilepsia; 2020 Dec; 61(12):2705-2711. PubMed ID: 33084053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.